PETVIVO HOLDINGS INC (PETV) Stock Price & Overview

NASDAQ:PETVUS7168174081

Current stock price

0.969 USD
-0.07 (-7%)
At close:
0.49 USD
-0.48 (-49.43%)
After Hours:

The current stock price of PETV is 0.969 USD. Today PETV is down by -7%. In the past month the price decreased by -10.28%. In the past year, price decreased by -64.63%.

PETV Key Statistics

52-Week Range0.55 - 2.8999
Current PETV stock price positioned within its 52-week range.
1-Month Range0.969 - 1.25
Current PETV stock price positioned within its 1-month range.
Market Cap
16.25M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.81
Dividend Yield
N/A

PETV Stock Performance

Today
-7%
1 Week
-3.10%
1 Month
-10.28%
3 Months
-22.48%
Longer-term
6 Months -49.53%
1 Year -64.63%
2 Years -52.73%
3 Years N/A
5 Years N/A
10 Years N/A

PETV Stock Chart

PETVIVO HOLDINGS INC / PETV Daily stock chart

PETV Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to PETV. When comparing the yearly performance of all stocks, PETV is a bad performer in the overall market: 93.24% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

PETV Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to PETV. Both the profitability and financial health of PETV have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PETV Earnings

On February 12, 2024 PETV reported an EPS of -0.07 and a revenue of 290.00K.

Next Earnings DateJun 27, 2024
Last Earnings DateFeb 12, 2024
PeriodQ3 / 2026
EPS Reported-$0.07
Revenue Reported290K
EPS Surprise %
Revenue Surprise %

PETV Forecast & Estimates

7 analysts have analysed PETV and the average price target is 7.14 USD. This implies a price increase of 636.84% is expected in the next year compared to the current price of 0.969.


Analysts
Analysts82.86
Price Target7.14 (636.84%)
EPS Next YN/A
Revenue Next YearN/A

PETV Groups

Sector & Classification

Index Membership

PETV Financial Highlights

Over the last trailing twelve months PETV reported a non-GAAP Earnings per Share(EPS) of -0.81. The EPS decreased by -6.65% compared to the year before.


Income Statements
Revenue(TTM)1.05M
Net Income(TTM)-10.63M
Industry RankSector Rank
PM (TTM) N/A
ROA -292.88%
ROE -1187.69%
Debt/Equity 0.16
Chartmill High Growth Momentum
EPS Q2Q%47.83%
Sales Q2Q%16.84%
EPS 1Y (TTM)-6.65%
Revenue 1Y (TTM)23.91%

PETV Ownership

Ownership
Inst Owners0.06%
Shares16.77M
Float10.47M
Ins Owners38.48%
Short Float %0.26%
Short Ratio0.67

PETV Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.14191.058B
ISRG INTUITIVE SURGICAL INC47.3171.691B
SYK STRYKER CORP23.11133.773B
BSX BOSTON SCIENTIFIC CORP19.96103.561B
EW EDWARDS LIFESCIENCES CORP27.7348.532B
IDXX IDEXX LABORATORIES INC39.5646.687B
BDX BECTON DICKINSON AND CO11.7645.635B
RMD RESMED INC18.7833.595B
GEHC GE HEALTHCARE TECHNOLOGY13.9632.892B
DXCM DEXCOM INC26.0925.532B
ZBH ZIMMER BIOMET HOLDINGS INC1118.254B
HOLX HOLOGIC INC15.3116.777B
PODD INSULET CORP34.7515.816B

About PETV

Company Profile

PETV logo image PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. The company is headquartered in Edina, Minnesota and currently employs 25 full-time employees. The company went IPO on 2012-07-10. The firm is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for animals. The Company’s lead product Spryng with OsteoCushion Technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The firm is primarily engaged in the business of commercializing and licensing products in the veterinary market to treat and/or manage afflictions of companion animals, such as dogs and horses. Its products are derived from biomaterials that simulate a body’s cellular tissue by virtue of their reliance upon natural protein and carbohydrate compositions, which incorporate such tissue building blocks as collagen, elastin, and proteoglycans such as heparin. The firm has a pipeline of therapeutic devices for both veterinary and human clinical applications.

Company Info

IPO: 2012-07-10

PETVIVO HOLDINGS INC

5251 Edina Industrial Blvd

Edina MINNESOTA US

CEO: John Lai

Employees: 25

PETV Company Website

Phone: 19522174952

PETVIVO HOLDINGS INC / PETV FAQ

What does PETV do?

PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. The company is headquartered in Edina, Minnesota and currently employs 25 full-time employees. The company went IPO on 2012-07-10. The firm is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for animals. The Company’s lead product Spryng with OsteoCushion Technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The firm is primarily engaged in the business of commercializing and licensing products in the veterinary market to treat and/or manage afflictions of companion animals, such as dogs and horses. Its products are derived from biomaterials that simulate a body’s cellular tissue by virtue of their reliance upon natural protein and carbohydrate compositions, which incorporate such tissue building blocks as collagen, elastin, and proteoglycans such as heparin. The firm has a pipeline of therapeutic devices for both veterinary and human clinical applications.


What is the current price of PETV stock?

The current stock price of PETV is 0.969 USD. The price decreased by -7% in the last trading session.


Does PETV stock pay dividends?

PETV does not pay a dividend.


What is the ChartMill rating of PETVIVO HOLDINGS INC stock?

PETV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What is the Price/Earnings (PE) ratio of PETVIVO HOLDINGS INC (PETV)?

PETVIVO HOLDINGS INC (PETV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.81).


Should I buy PETV stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PETV.